Back to search
Nonradiographic Axial Spondyloarthritis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Nonradiographic Axial Spondyloarthritis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Nonradiographic Axial Spondyloarthritis trials you may qualify forThe purpose of the study is to demonstrate the long-term safety, tolerability and efficacy of bimekizumab in patients with active axial spondyloarthritis (axSpA…
The purpose of the study is to demonstrate the efficacy, safety and tolerability of bimekizumab administered subcutaneously (sc) compared to placebo in the trea…
Patients with active Axial Spondyloarthritis without x-ray evidence of Ankylosing Spondylitis and with signs of inflammation will be randomly assigned to receiv…
The investigators aimed to study the associations between exercise capacity and cardiovascular (CV) risk factors in axial spondyloarthritis (axSpA) patients and…
The main purpose of this study is to evaluate the safety and efficacy of the study drug known as ixekizumab in biologic disease modifying antirheumatic drug (bD…
The purpose of this study is to assess the efficacy and safety of ustekinumab in adult participants with active nonradiographic axial spondyloarthritis (nr-AxSp…